PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.97%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
4.69%
Positive gross profit growth while 4997.T is negative. John Neff would see a clear operational edge over the competitor.
434.88%
EBIT growth of 434.88% while 4997.T is zero. Bruce Berkowitz would see if small gains can be scaled further.
362.79%
Positive operating income growth while 4997.T is negative. John Neff might view this as a competitive edge in operations.
387.54%
Net income growth above 1.5x 4997.T's 75.29%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
387.81%
EPS growth above 1.5x 4997.T's 75.38%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
387.81%
Diluted EPS growth above 1.5x 4997.T's 75.38%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.55%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-86.55%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-86.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
103.02%
Net income/share CAGR 1.25-1.5x 4997.T's 76.23%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
103.02%
5Y net income/share CAGR 1.25-1.5x 4997.T's 76.23%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
103.02%
3Y net income/share CAGR 1.25-1.5x 4997.T's 76.23%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
6.55%
Inventory shrinking or stable vs. 4997.T's 49.67%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
11.55%
Asset growth above 1.5x 4997.T's 4.72%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.91%
Positive BV/share change while 4997.T is negative. John Neff sees a clear edge over a competitor losing equity.
34.72%
We have some new debt while 4997.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.